𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Increased risk of hepatocellular carcinoma among patients with hepatitis C cirrhosis and diabetes mellitus

✍ Scribed by Bart J. Veldt; Wendong Chen; E. Jenny Heathcote; Heiner Wedemeyer; Juerg Reichen; W. Peter Hofmann; Robert J. de Knegt; Stefan Zeuzem; Michael P. Manns; Bettina E. Hansen; Solko W. Schalm; Harry L. A. Janssen

Publisher
John Wiley and Sons
Year
2008
Tongue
English
Weight
226 KB
Volume
47
Category
Article
ISSN
0270-9139

No coin nor oath required. For personal study only.

✦ Synopsis

Recent studies suggest that diabetes mellitus increases the risk of developing hepatocellular carcinoma (HCC). The aim of this study is to quantify the risk of HCC among patients with both diabetes mellitus and hepatitis C in a large cohort of patients with chronic hepatitis C and advanced fibrosis. We included 541 patients of whom 85 (16%) had diabetes mellitus. The median age at inclusion was 50 years. The prevalence of diabetes mellitus was 10.5% for patients with Ishak fibrosis score 4, 12.5% for Ishak score 5, and 19.1% for Ishak score 6. Multiple logistic regression analysis showed an increased risk of diabetes mellitus for patients with an elevated body mass index (BMI) (odds ratio [OR], 1.05; 95% confidence interval [CI], 1.00-1.11; P = 0.060) and a decreased risk of diabetes mellitus for patients with higher serum albumin levels (OR, 0.81; 95% CI, 0.63-1.04; P = 0.095). During a median follow-up of 4.0 years (interquartile range, 2.0-6.7), 11 patients (13%) with diabetes mellitus versus 27 patients (5.9%) without diabetes mellitus developed HCC, the 5-year occurrence of HCC being 11.4% (95% CI, 3.0-19.8) and 5.0% (95% CI, 2.2-7.8), respectively (P = 0.013). Multivariate Cox regression analysis of patients with Ishak 6 cirrhosis showed that diabetes mellitus was independently associated with the development of HCC (hazard ratio, 3.28; 95% CI, 1.35-7.97; P = 0.009).

Conclusion:

For patients with chronic hepatitis c and advanced cirrhosis, diabetes mellitus increases the risk of developing hcc.

πŸ“œ SIMILAR VOLUMES

Hepatic steatosis is associated with inc
Hepatic steatosis is associated with increased frequency of hepatocellular carcinoma in patients with hepatitis C-related cirrhosis
✍ Joel R. Pekow; Atul K. Bhan; Hui Zheng; Raymond T. Chung πŸ“‚ Article πŸ“… 2007 πŸ› John Wiley and Sons 🌐 English βš– 98 KB πŸ‘ 2 views

## Abstract ## BACKGROUND. Chronic hepatitis C can result in fatty changes in the liver. Previous studies have suggested that hepatic steatosis is a risk factor for hepatocellular carcinoma in patients with hepatitis C virus (HCV) infection. The authors sought to determine whether hepatic steatosi

Patients with cirrhosis and bare-stent T
Patients with cirrhosis and bare-stent TIPS may have increased risk of hepatocellular carcinoma
✍ Rafael BaΓ±ares; Oscar NΓΊΓ±ez; MarΓ­a Escudero; Cristina FernΓ‘ndez; Javier Vaquero; πŸ“‚ Article πŸ“… 2005 πŸ› John Wiley and Sons 🌐 English βš– 119 KB πŸ‘ 1 views

A trend toward a higher incidence of hepatocelullar carcinoma (HCC) in patients with cirrhosis treated with bare-stent transjugular intrahepatic portosystemic shunt (TIPS) has been observed in previous studies. To assess the influence of TIPS as a risk factor for developing HCC, we have compared the

Reduced risk of prostate cancer among pa
Reduced risk of prostate cancer among patients with diabetes mellitus
✍ Elisabete Weiderpass; Weimin Ye; Harri Vainio; Rudolf Kaaks; Hans-Olov Adami πŸ“‚ Article πŸ“… 2002 πŸ› John Wiley and Sons 🌐 French βš– 70 KB πŸ‘ 1 views

## Abstract Although diabetes mellitus is associated with an increased risk of several malignancies, a negative association with prostate cancer is biologically most plausible. The epidemiologic evidence is, however, inconsistent, limited and based mostly on small studies. We present results from a